Literature DB >> 11716839

Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives.

A Lampen1, C Carlberg, H Nau.   

Abstract

The antiepileptic drug valproic acid (2-propylpentanoic acid) is a potent teratogen in both humans and mice. Valproic acid can induce differentiation of F9 teratocarcinoma cells and stimulate peroxisome proliferator-activated receptor (PPAR) activity. In this study, the structure-activity relationship between valproic acid, its teratogenic and non-teratogenic analogues (branched small- and medium chain fatty acids) and the three PPAR subtypes alpha, gamma or delta was investigated. PPAR-alpha and PPAR-gamma were activated by some valproic acid-derivatives; however, no correlation between teratogenicity and receptor activation could be observed. In contrast, only valproic acid and exclusively its teratogenic analogues were able to activate PPAR-delta in different cellular systems. However, valproic acid appears not to be a direct ligand of PPAR-delta, since in contrast to carbaprostacyclin (cPGI), valproic acid showed not to be able to induce complex formation of PPAR-delta-retinoid X receptor (RXR) heterodimers on DNA. In conclusion, in contrast to PPAR-alpha and PPAR-gamma, PPAR-delta shows to be a specific sensor for teratogenic valproic acid-derivatives.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716839     DOI: 10.1016/s0014-2999(01)01423-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.

Authors:  Jitendriya Mishra; Tanya Chaudhary; Anil Kumar
Journal:  Neurotox Res       Date:  2014-02-25       Impact factor: 3.911

2.  Valproyl-CoA and esterified valproic acid are not found in brains of rats treated with valproic acid, but the brain concentrations of CoA and acetyl-CoA are altered.

Authors:  Joseph Deutsch; Stanley I Rapoport; Thad A Rosenberger
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

3.  Neuronal peroxisome proliferator-activated receptor gamma signaling: regulation by mood-stabilizer valproate.

Authors:  Martin J Lan; Peixiong Yuan; Guang Chen; Husseini K Manji
Journal:  J Mol Neurosci       Date:  2008-04-25       Impact factor: 3.444

4.  Differential transcriptional expression of PPARalpha, PPARgamma1, and PPARgamma2 in the peritoneal macrophages and T-cell subsets of non-obese diabetic mice.

Authors:  Nik-Soriani Yaacob; Mohd Arifin Kaderi; Mohd-Nor Norazmi
Journal:  J Clin Immunol       Date:  2009-05-27       Impact factor: 8.317

Review 5.  Regulation of Ketone Body Metabolism and the Role of PPARα.

Authors:  Maja Grabacka; Malgorzata Pierzchalska; Matthew Dean; Krzysztof Reiss
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

6.  Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression.

Authors:  Sabine Seuter; Sami Heikkinen; Carsten Carlberg
Journal:  Nucleic Acids Res       Date:  2012-10-23       Impact factor: 16.971

7.  Branched-Chain Fatty Acids as Mediators of the Activation of Hepatic Peroxisome Proliferator-Activated Receptor Alpha by a Fungal Lipid Extract.

Authors:  Garima Maheshwari; Robert Ringseis; Gaiping Wen; Denise K Gessner; Johanna Rost; Marco A Fraatz; Holger Zorn; Klaus Eder
Journal:  Biomolecules       Date:  2020-08-31

8.  Valproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro model.

Authors:  Alexandra M E Zuckermann; Roberto M La Ragione; Deborah L Baines; Robin S B Williams
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.